Advanced Training in Urologic Oncology

泌尿肿瘤学高级培训

• 批准号: 10646219
• 负责人: Ganesh S Palapattu
• 金额: $ 31.96万
• 依托单位: UNIVERSITY OF MICHIGAN AT ANN ARBOR
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-08-22 至 2024-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10646219
• 关键词: Training; Urologic Oncology

Urologic cancers impose a significant burden on the health of Americans with 63,000 individuals succumbing to the malignancies each year. These numbers are expected to rise over the next several decades as the population ages. At the same time, the pace of innovation and discovery in cancer-oriented translational science and health services research continues to accelerate. Thus, a well-prepared research-oriented work force capable of answering important scientific questions is needed. Unfortunately, traditional clinical training in urologic oncology falls short of this need. The goal of this T32 renewal application is to prepare urology trainees for academic careers in urologic oncology by providing a comprehensive research training program in translational laboratory science or health services research. This proposal is a renewal application to educate 2 research trainees per year for 2 years of training. The program is structured around a research project supervised by an individualized mentorship committee, including both research and methods mentors, an interactive and informative series of seminars and a required core curriculum that includes specific graduate level courses that may lead to a Master’s degree. Entrants to the program will choose between a translational laboratory science or health services research track depending on their interests. The program will ensure that each trainee: 1) design, implement, analyze and report a research project, 2) obtain formal instruction on fundamental research methods, 3) gain instruction on either fundamental principles of cancer biology (translational science track) or essential elements of conducting health services research (health services track) and 4) acquire requisite professional skills (e.g., grant writing) to support and sustain a research career.

泌尿系统癌症给美国人的健康带来了沉重的负担，有63，000人死于泌尿系统癌症。 恶性肿瘤的发病率。预计这些数字将在未来几十年内上升， 人口老龄化。与此同时，创新和发现的步伐，在癌症为导向的翻译 科学和卫生服务研究继续加速。因此，一个精心准备的研究型工作 需要能够回答重要科学问题的力量。不幸的是，传统的临床训练 泌尿肿瘤学福尔斯不能满足这种需要。本次T32更新申请的目标是为泌尿外科做好准备 通过提供全面的研究培训计划， 转化实验室科学或卫生服务研究。此建议书是一份更新申请， 每年培训研究学员2年。该计划是围绕一个研究项目的结构 由个别指导委员会监督，包括研究和方法导师， 互动和信息丰富的系列研讨会和必要的核心课程，包括具体的研究生 可能导致硕士学位的水平课程。该计划的参赛者将在翻译 实验室科学或卫生服务研究轨道取决于他们的兴趣。该计划将确保， 每个学员：1）设计，实施，分析和报告一个研究项目，2）获得正式指导， 基本研究方法，3）获得癌症生物学基本原理的指导 （转化科学轨道）或进行卫生服务研究的基本要素（卫生服务 轨道）和4）获得必要的专业技能（例如，资助写作），以支持和维持研究生涯。

项目成果

Medicare Accountable Care Organizations and Use of Potentially Low-Value Procedures.

医疗保险责任医疗组织和潜在低价值程序的使用。

• DOI: 10.1177/1553350618816594
• 发表时间: 2019
• 期刊: Surgical innovation
• 影响因子: 1.5
• 作者: Modi,ParthK;Kaufman,SamuelR;Borza,Tudor;Oliphant,BryantW;Ryan,AndrewM;Miller,DavidC;Shahinian,VahaknB;Ellimoottil,Chad;Hollenbeck,BrentK
• 通讯作者: Hollenbeck,BrentK

Implications of the Merit-Based Incentive Payment System for Urology Practices.

• DOI: 10.1016/j.urology.2022.05.052
• 发表时间: 2022-11
• 期刊: UROLOGY
• 影响因子: 2.1
• 作者: Maganty, Avinash;Hollenbeck, Brent K.;Kaufman, Samuel R.;Oerline, Mary K.;Lai, Lillian Y.;Caram, Megan E., V;Shahinian, Vahakn B.
• 通讯作者: Shahinian, Vahakn B.

Real-World Impact of Minimally Invasive Versus Open Radical Cystectomy on Perioperative Outcomes and Spending.

最小侵入性与开放式膀胱切除术对围手术期和支出的实际影响。

• DOI: 10.1016/j.urology.2018.10.022
• 发表时间: 2019-03
• 期刊: Urology
• 影响因子: 2.1
• 作者: Modi PK;Hollenbeck BK;Oerline M;Weizer AZ;Montgomery JS;Kaffenberger SD;Ryan AM;Ellimoottil C
• 通讯作者: Ellimoottil C

The immediate effects of private equity acquisition of urology practices on the management of newly diagnosed prostate cancer.

• DOI: 10.1002/cam4.6788
• 发表时间: 2023-12
• 期刊: Cancer medicine
• 影响因子: 4

Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care.

Medicare共享储蓄计划的早期影响负责任的护理组织参与前列腺癌护理。

• DOI: 10.1002/cncr.31081
• 发表时间: 2018-02-01
• 期刊: Cancer
• 影响因子: 6.2
• 作者: Borza T;Kaufman SR;Yan P;Herrel LA;Luckenbaugh AN;Miller DC;Skolarus TA;Jacobs BL;Hollingsworth JM;Norton EC;Shahinian VB;Hollenbeck BK
• 通讯作者: Hollenbeck BK